Related Experiment Video

Updated: Dec 12, 2025

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.8K

Some New and Unexpected Tauopathies in Movement Disorders

Eoin Mulroy1, Zane Jaunmuktane1,2, Bettina Balint1,3

  • 1Department of Clinical and Movement Neurosciences UCL Queen Square Institute of Neurology London United Kingdom.

Movement Disorders Clinical Practice
|August 11, 2020
PubMed
Abstract

No abstract available in PubMed .

Keywords:
movement disordersneuropathologytauopathies

More Related Videos

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
10:02

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Published on: May 28, 2017

27.7K
Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins
12:47

Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins

Published on: December 27, 2016

19.2K

Related Experiment Videos

Last Updated: Dec 12, 2025

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.8K
Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
10:02

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Published on: May 28, 2017

27.7K
Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins
12:47

Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins

Published on: December 27, 2016

19.2K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

824
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
824

Articles linked to this work by shared authors, journal, and citation graph.

Defining the underlying pathology of corticobasal syndrome using clinical features and biomarkers.

Brain : a journal of neurology·2026

Multimodal assessment of clinical and neural changes following multidisciplinary management in functional motor disorders.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Televisits for Parkinson's disease: benefits and barriers.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Sensory Tricks in Dystonia: A Systematic Review and Nested Quantitative Synthesis.

Brain and behavior·2026

Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases.

Neurology·2026

The Pick fold in tau filaments from human MAPT mutants.

Acta neuropathologica·2026

DYT-PRKRA Dystonia-Parkinsonism with Pathological Startle: Expanding the Phenotype of PRKRA-Related Disease.

Movement disorders clinical practice·2026

Anti-Amphiphysin Stiff-Person Spectrum Disorders: A Systematic Review and Case Series Featuring an Unusual Isolated Upper-Limb Presentation.

Movement disorders clinical practice·2026

Exercise and Motor Complications in Parkinson's Disease: A Systematic Review and Meta-Analysis.

Movement disorders clinical practice·2026

Clinical Approach to Impulse Control-Related Behavioral Disorders in Parkinson's Disease: A Scoping Review.

Movement disorders clinical practice·2026

Staged Bilateral Magnetic Resonance-Guided Focused Ultrasound for Treating Essential Tremor: Systematic Review and Meta-Analysis.

Movement disorders clinical practice·2026

Combined Transcranial Sonography of the Substantia Nigra and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Parkinson's Disease and Atypical Parkinsonian Syndromes.

Movement disorders clinical practice·2026

Impact of Non-Tobacco Nicotine Dependence on Outcomes Following Arthroscopic Partial Meniscectomy.

Orthopedics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us